Fluvoxamine and long COVID: Post‐acute recovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fluvoxamine and long COVID: Post‐acute recovery

Published:2024-06-02 Issue:4 Volume:34 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Reviews in Medical Virology

Author:

Reiersen Angela M.¹^ORCID,Zorumski Charles F.¹,Lenze Eric J.¹

Affiliation:

1. Department of Psychiatry School of Medicine Washington University in St. Louis St. Louis Missouri USA

Funder

Cures Within Reach

National Center for Advancing Translational Sciences

Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2557

Reference8 articles.

1. Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis

2. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

3. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

4. The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications;Scientific Reports;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP